Barclays’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.43M | Sell |
256,384
-22,067
| -8% | -$812K | ﹤0.01% | 1196 |
|
|
2025
Q1 | $9.85M | Sell |
278,451
-130,163
| -32% | -$4.6M | ﹤0.01% | 1023 |
|
|
2024
Q4 | $17.9M | Buy |
408,614
+113,950
| +39% | +$4.98M | 0.01% | 828 |
|
|
2024
Q3 | $13.4M | Buy |
294,664
+192,021
| +187% | +$8.71M | ﹤0.01% | 897 |
|
|
2024
Q2 | $3.98M | Sell |
102,643
-32,773
| -24% | -$1.27M | ﹤0.01% | 1291 |
|
|
2024
Q1 | $4.36M | Sell |
135,416
-218,369
| -62% | -$7.04M | ﹤0.01% | 1450 |
|
|
2023
Q4 | $10.1M | Buy |
353,785
+125,124
| +55% | +$3.59M | ﹤0.01% | 1049 |
|
|
2023
Q3 | $6.33M | Buy |
228,661
+42,336
| +23% | +$1.17M | ﹤0.01% | 1029 |
|
|
2023
Q2 | $4.98M | Buy |
186,325
+38,376
| +26% | +$1.03M | ﹤0.01% | 1228 |
|
|
2023
Q1 | $3.21M | Buy |
147,949
+5,950
| +4% | +$129K | ﹤0.01% | 1339 |
|
|
2022
Q4 | $3.38M | Sell |
141,999
-27,918
| -16% | -$665K | ﹤0.01% | 1331 |
|
|
2022
Q3 | $3.35M | Buy |
169,917
+139,256
| +454% | +$2.75M | ﹤0.01% | 1326 |
|
|
2022
Q2 | $598K | Sell |
30,661
-7,052
| -19% | -$138K | ﹤0.01% | 2456 |
|
|
2022
Q1 | $962K | Buy |
+37,713
| New | +$962K | ﹤0.01% | 2348 |
|